What is BoobyBiome?
BoobyBiome is at the forefront of developing innovative products derived from breast milk microbiome science, aiming to bolster infant health. The company's core mission is to ensure that all infants can access the health benefits of breast milk, irrespective of their feeding method. Founded by a dedicated team of female scientists, BoobyBiome actively partners with premier research institutions to tackle the widespread issues of low breastfeeding rates and underdeveloped infant microbiomes. Their work is motivated by the urgent need to improve infant well-being amidst a global increase in infant-related diseases.
How much funding has BoobyBiome raised?
BoobyBiome has raised a total of $3.3M across 1 funding round:
Seed
$3.3M
Seed (2025): $3.3M, investors not publicly disclosed
What's next for BoobyBiome?
With this major enterprise-level funding, BoobyBiome is poised for significant expansion and further research and development. The strategic investment signals strong confidence from backers in the company's unique approach to infant health. Future initiatives will likely focus on scaling production, expanding clinical trials, and broadening market reach to make their innovative solutions accessible to a wider population. This capital will be instrumental in advancing their mission to enhance infant health through the power of the breast milk microbiome.
See full BoobyBiome company page
